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Background: There is consistent evidence that community and clinical samples of
individuals with an alcohol use disorder (AUD) have attentional biases toward alcohol
cues. The alcohol attentional control training program (AACTP) has shown promise for
retraining these biases and decreasing alcohol consumption in community samples of
excessive drinkers. However, there is a lack of evidence regarding the effectiveness of
ACTP in clinical AUD samples. Themain aim of the present study is to investigate whether
primary pharmacological and psychological, evidence-based alcohol treatment can be
enhanced by the addition of a gamified AACTP smartphone application for patients with
an AUD.
Design and Methods: The study will be implemented as a randomized controlled
trial. A total of 317 consecutively enrolled patients with AUD will be recruited from
alcohol outpatient clinics in Denmark. Patients will be randomized to one of three groups
upon initiation of primary alcohol treatment: Group A: a gamified AACTP smartphone
application + treatment as usual (TAU); Group B: a gamified AACTP sham-control
application + TAU; or Group C: only TAU. Treatment outcomes will be assessed
at baseline, post-treatment, and at 3- and 6-month follow-ups. Repeated measures
MANOVA will be used to compare the trajectories of the groups over time on alcohol
attentional bias, alcohol craving, and drinking reductions. It is hypothesized that Group
A will achieve better treatment outcomes than either Group B or Group C.
Perspectives: Because attentional bias for alcohol cues is proportional to the amount
of alcohol consumed, and these biases are not addressed within current evidence-based
treatment programs, this study is expected to provide new evidence regarding the
effectiveness of the gamified AACTP in a clinical population. Furthermore, due to
promising results found using AACTP in community samples of excessive drinkers, there
is a high probability that the AACTP treatment in this study will also be effective, thereby
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allowing AACTP to be readily implemented in clinical settings. Finally, we expect that this
study will increase the effectiveness of evidence-based AUD treatment and introduce a
new, low-cost gamified treatment targeting patients with an AUD. Overall, this study is
likely to have an impact at the scientific, clinical, and societal levels.
Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT05102942?term=
NCT05102942&draw=2&rank=1, identifier: NCT05102942.
Keywords: alcohol use disorder, attentional bias, Stroop task, cognitive bias modification, add-on treatment,
randomized clinical trial
BACKGROUND
Alcohol-use disorder (AUD), as defined by DSM-5 criteria, is
very common in the Western world, with a 12-month prevalence
of 14% and a lifetime prevalence of 29% (1). Furthermore, AUD
is the most prevalent and most harmful of all substance-use
disorders (2, 3) and is among the leading causes of illness,
disability, and mortality (4, 5). The high prevalence and severity
of AUD underscore the importance of having easily available and
effective treatments.
Overall, evidence-based psychological treatments, such as
cognitive-behavioral therapy (CBT), have shown to be effective
in the short term (6). During CBT, patients with an AUD are
taught methods to help them identify high-risk situations for
relapse. They also learn coping strategies for avoiding alcohol
in high-risk situations. Patients are, however, supposed to learn
these strategies by applying explicit and controlled cognitive
techniques rather than practicing the strategies while being
exposed to alcohol in vivo (7–9). Recovering patients often
experience a relapse when they are exposed to alcohol and
related stimuli in real-life, and they can only later analyze the
consequences of their behavior. Patients with an AUD initially
respond well to evidence-based psychological treatments, but as
many as 50% of them relapse within 6 months after treatment
discharge (10–12). This indicates that CBT and other evidence-
based psychological treatments do not address all the crucial
cognitive dysfunctions associated with maintaining an addiction;
thus, they may not prepare patients to deal with their inevitable
confrontation with alcohol cues in real life in Western societies.
One shortcoming of current psychological treatments is that
they mainly target explicit and controlled cognitive dysfunctions.
However, according to dual process models of addictive
behaviors, confrontation with alcohol cues in vivo is influenced
by two semi-independent cognitive systems: (1) a fast associative
impulsive system, which is involved in the automatic evaluation
of alcohol-related stimuli in the environment in terms of their
Abbreviations: AASE, alcohol abstinence self-efficacy scale; AAT, Alcohol
approach-avoidance task; AB, attentional bias; A-GNG, Alcohol Go/No-Go; ACTP,
attention control training program; AUD, alcohol use disorder; CBT, cognitive
behavior therapy; ETG, ethyl glucuronide; LC-MS/MS, liquid chromatography-
tandem mass spectrometry; MSFVT, Multi-stimulus free-viewing task; MoCA,
Montreal Cognitive Assessment.; PANAS, Positive and Negative Affect Schedule;
RTCQ-TV, Readiness-to-Change Questionnaire Treatment Version; RT, reaction
time; TAU, treatment as usual; TLFB, timeline follow-back; VAS, Visual Analog
Scale.
emotional and motivational significance and which initiates
approach or avoidance responses; and (2) a slow and controlled
reflective system, which is involved in the regulation of the
automatic and implicit responses elicited by the impulsive
system, and which is responsible for explicit and controlled,
higher-order cognitive processes (13–16).
Addictive behaviors, such as AUD, can be conceptualized
as a dysfunction of these systems, whereby an over-activated
impulsive system becomes sensitized and triggers approach
behaviors toward alcohol cues, whereas a relatively under-
activated reflective system is unable to regulate the behavior.
Because the impulsive system is partly automatic and implicit,
approach behaviors targeting alcohol cues in the environment
allow the self-destructive drinking behavior to be maintained,
even though the drinker might have explicit knowledge about
the consequences generated by the reflective system (15, 16).
Corroborating evidence from functional neuroimaging studies
suggest that patients with AUD exhibit aberrant activation
in dorsolateral prefrontal cortex, insular cortex, and anterior
cingulate cortex, which are structures that act as a critical part of
the reflective system (17–21). In addition to the of hypoactivation
of the neural correlates for the reflective system, hyperactivation
of subcortical structures such as ventral striatum and nucleus
accumbens have also been found in AUD, which underlines the
notion of a dysfunctional interaction between the reflective and
impulsive systems (19–22). Although standard evidence-based
psychological treatments for AUD target and attempt to modify
dysfunctions in one of the cognitive systems that influence the
maintenance of an AUD, the impulsive cognitive dysfunctions are
addressed to a much lesser extent.
A cognitive dysfunction in the impulsive system that has
consistently been identified as a crucial component in the
maintenance of an AUD is alcohol attentional bias (AB). An
AB for alcohol cues refers to the implicit and automatic
cognitive process of selectively focusing attention on alcohol-
related stimuli in the environment at the expense of processing
other relevant stimuli (23, 24). AB for alcohol cues has been
measured by using a variety of experimental paradigms (25).
Among the most widely used paradigm is the alcohol variant
of the experimental Stroop task (24, 26, 27). The alcohol Stroop
consists of two categories of stimuli: alcohol-related (e.g., beer,
wine, tavern) and neutral (e.g., chair, envelop, juice). During
the task participants are asked to name the color (i.e., red,
yellow, blue, or green) in which each stimulus appears as fast
and accurately as possible while ignoring their content and
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FIGURE 1 | Alcohol attention control training program: In Level 1, neutral or alcohol stimuli are successively presented on the screen, while the colored background of
the screen needs to be identified. In Level 2, instead of the background, a colored outline needs to be identified. In Level 3, neutral and alcohol stimuli appear
simultaneously of which the neutral stimulus needs to be identified.
meaning. The degree of AB is indicated by slower mean reaction
times to alcohol cues compared to neutral cues and is calculated
as an interference score. The alcohol-related meaning of the
stimuli is presumably either capturing the person’s attention
more readily or maintaining the attentional focus for a longer
period of time than the neutral cues (24). AB as measured by
the alcohol Stroop task has consistently been found in both
community and clinical samples of excessive drinkers (28–31),
and the degree of AB is proportional to the amount of alcohol that
participants habitually consume (24). For example, clinical AUD
samples exhibit greater AB than sub-clinical samples of heavy
drinkers (24, 29, 32). In addition, the degree of AB is inversely
related to drinkers’ ability to control their drinking (31, 33–35).
Finally, it has been shown that clinical samples of AUD patients
who have stronger alcohol AB at treatment admission are more
likely to have an unsuccessful treatment outcome compared to
patients with less AB, and the degree of AB of the unsuccessful
patients increased during the course of treatment, suggesting
that abstinence increases attentional awareness of alcohol cues
(28). Taken together, the research suggests that AB is of utmost
importance in maintaining an AUD and if not corrected, it might
impede the effectiveness of other treatments and cause the patient
to relapse.
The principles underlying the experimental alcohol Stroop
task have recently been applied in the Alcohol Attention Control
Training Program (AACTP), which is a computerized training
program aimed at increasing drinkers’ cognitive control over
their alcohol AB. As illustrated in Figure 1, the AACTP consists
of three different levels of training.
At Level 1, individual pictorial stimuli with a colored
background (e.g., red, or green) are shown one at a time on
a computer screen. Each stimulus is either alcohol-related or
neutral. The participant is instructed to ignore the content of
the stimuli while naming the color of the background. At Level
2, again an alcohol-related and a neutral stimulus is presented
successively on the computer screen one at a time. In contrast
to Level 1 in which the pictures have a colored background,
the pictures now have only a colored outline whose color the
participant is supposed to identify, thus making the task more
difficult than at Level 1. At Level 3, two stimuli (an alcohol-
related one and a neutral one) are presented simultaneously
on the computer screen. The participant is asked to identify as
quickly and accurately as possible the outline color of the neutral
stimulus, while ignoring the alcohol-related stimulus.
The AACTP uses a variety of pictorial alcohol-related stimuli
to train participants to progressively divert their attention
away from alcohol-stimuli, with increasing levels of difficulty
across the training. The alcohol AACTP has been evaluated
in community samples of excessive drinkers who have shown
reductions in both AB and alcohol consumption at post-
treatment and follow-up (32, 36, 37). Recent reviews and
meta-analyses do point to methodological shortcomings and
conflicting evidence on the effects of training programs targeting
AB across patients with various addictive disorders, including
AUD (38–40). Despite the need for more well-designed studies,
there is, however, also evidence suggesting that AACTP may
be more promising for targeting alcohol consumption when
compared to other AB training programs (40). Furthermore, the
ACTP has been studied as an add-on treatment among clinical
populations with food- and opiate addictions. In both cases,
the addition of the ACTP in the experimental group led to a
greater reduction in disease-specific AB and the accompanying
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unhealthy behavior than in the control groups (41, 42). This
evidence suggests that AACTP might be a promising tool
for ameliorating AB in clinical samples of patients with an
AUD, especially when used in conjunction with a conventional
treatment for AUDs.
In contrast to many other psychological treatments, clinical
neuropsychological treatments building on experimental
laboratory tasks are particularly suitable for alternative delivery
pathways, such as tablets and mobile applications. These
delivery pathways make it possible to use gamification elements,
which would increase patients’ motivation to participate.
Gamification is defined as the use of game-design features in
a non-gaming context, such as in a psychological treatment
setting. Gamification would make the intervention more
engaging, enjoyable, and motivating for participants (43), and
using gamification elements is likely to enhance compliance
with neuropsychological treatments. Commonly used gaming
techniques include time-pressure, sound effects, feedback,
progression in level of difficulty, achievement rankings, and
competition (43–45). Although the AACTP have shown great
promise in treating cognitive dysfunctions not targeted by
conventional psychological treatments, the use of gamification
elements may enhance compliance with and the effectiveness of
these interventions.
Taken together, the results of prior studies are promising in
terms of the clinical relevance of AB training. However, the small
number of studies with small sample sizes conducted to date
highlights the need for future research to verify the robustness of
thesemostly positive findings in actual clinical AUD settings (40).
Further, adding gamification elements may increase compliance
and hence the effectiveness of the intervention.
Aims
The main aim of the study is to determine whether a
gamified version of the AACTP when used as an add-on to a
primary evidence-based treatment will increase the treatment’s
effectiveness. Based on the available evidence, it is hypothesized
that the experimental group (Group A) will achieve a better
treatment outcome than either the active control group (Group
B) or the treatment-as-usual group (Group C). Additionally,
we hypothesize that there will be a dose-response effect in
Group A: the more that the patients use the AACTP, the better
their outcome will be. Full descriptions of the experimental and
control groups are provided in Section 2.5 below.
METHODS
The study (a) will be registered in ClinicalTrials.gov, which
is the largest registry of clinical trials and is administered by
the United States National Library of Medicine (NLM) at the
National Institutes of Health, and (b) will be conducted and
reported according to CONSORT guidelines (46).
Design and Setting
The study will be conducted as a parallel randomized controlled
study in various outpatient alcohol treatment clinics in Denmark.
Most individuals with AUD who present themselves for
treatment at these clinics are offered outpatient treatment.
This outpatient treatment is financed through public funds. It
accepts self-referrals, and patients can remain anonymous during
treatment. Only treatment for alcohol problems is provided at the
outpatient clinics.
Primary Treatment at the Outpatient
Alcohol Clinics
At treatment entry, patients will be offered detoxification, if
needed, before their primary treatment at one of the outpatient
clinics is initiated. The primary treatment lasts 3 months
and consists of both a pharmacological and a psychological
treatment. The pharmacological treatment includes treatment
with disulfiram and acamprosate. Naltrexone or nalmefene is also
offered when deemed appropriate. The psychological treatment
consists of cognitive-behavioral therapy (CBT), which is provided
during hour-long individual or group sessions and typically
includes eight sessions. The therapist and patient jointly plan the
course of the patient’s treatment. The treatment typically includes
psychoeducation, functional analysis of drinking situations,
and the development of coping strategies. The strategies
include waiting out until an urge passes rather than acting
on it, thinking about the negative consequences of drinking,
thinking about the positive consequences of sobriety, consuming
healthy alternative foods and beverages, problem-solving, and
homework assignments between sessions. Therapists conduct
the psychological treatment; they include nurses and social
workers who have been specifically trained to deliver the range
of therapies. Supervision takes place frequently, and psychiatrists
regularly monitor patients’ progress during the treatment (47).
Recruitment
Based on a power calculation (see Section 2.7.), a total of 317
patients will be required for the data analysis. On the basis of data
from the Danish National Alcohol Treatment Register (48) and
prior studies conducted at this clinic (49–52) and prior studies
of AACTP (32, 36, 42), it seems feasible that at least 317 eligible
patients (see Section 2.4.) can be recruited from January 2021 to
July 2022.
After completing detoxification and prior to starting primary
treatment, each patient will be briefly informed about the project
and asked whether he or she is willing to meet with a research
assistant who will provide further information about the study. If
the patient agrees, the research assistant will provide the patient
with oral and written information about the details of the study.
After informed consent has been provided, a baseline interview
will be conducted, and each patient meeting the eligibility criteria
will be randomized. Tominimize the risk of bias and to overcome
potential group imbalances, the current study will utilize an urn
technique that will randomize the patients to one of the three
treatment groups.
Eligibility Criteria
To be eligible to participate, patients must fulfill the following
criteria. They must (1) sign written informed consent, (2) be
between 18 and 65 years old (because the intervention is web-
based), (3) be fluent in Danish, (4) have completed detoxification
(if deemed appropriate), (5) have been admitted to primary
treatment within the past 8 weeks, (6) not be color-blind, (7)
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not have a severe psychiatric or neurological illness (e.g., a
psychotic disorder, intellectual disability, dementia) or terminal
physical illness.
Experimental and Control Groups
The 317 patients (see power analysis below) fulfilling the
eligibility criteria will be randomized to one of the three groups:
Group A: AACTP delivered via a smartphone application +
treatment as usual (TAU; n = 106), Group B: ACTP sham
training delivered via a smartphone application + TAU (n =
106), or Group C: TAU only (n = 106). Patients in Group A
will receive seven sessions of AACTP (one session per week for
7 weeks). Patients in Group B will receive seven sessions of sham
training (one session per week for 7 weeks). Patients in Group C
will receive only the primary treatment for AUD. Patients in the
AACTP and sham control groups will start the primary treatment
within the 1st month of their admission, so that the add-on
treatment will not extend beyond the 3-month treatment period.
Attentional Control Training Program via a
Smartphone Application
The AACTP, which is delivered via a smartphone application and
based on an Android application, was designed in accordance
with the conventional AACTP to help drinkers become aware
of the automatic cognitive aspects of their alcohol use. The
stimuli comprise alcohol-related pictures and non-alcohol-
related pictures and are individually presented on a computer
screen in a random order. If patients need it, a research assistant
in the treatment facility will assist them with the installation
of the application on their smartphone. The installation of the
application on patients’ personal smartphone will allow them
to complete the training program at home. Thus, they will
not be constrained by having to use the application in the
outpatient facility.
The AATCP training will consist of seven sessions, each
of which takes 10–15min to complete. Each session will start
with practice with individual stimuli (i.e., Levels 1 and 2 in
the original AACTP) and proceed to Level 3, in which the
patient will be asked to either (a) identify the green outline
color of a non-alcohol-related picture, while ignoring the red
outline color of the alcohol-related picture presented adjacent
to it (stimulus-irrelevant version), or (b) identify the picture
with non-alcohol-related content, while ignoring the picture
with alcohol-related content presented adjacent to it (stimulus-
relevant version). Level 3 is the most difficult and most effective
level in the conventional AACTP. It is defined as the level in
which the patient is trained to divert his or her attention away
from alcohol cues when both an alcoholic and a non-alcoholic
stimulus is present, and they compete for the patient’s attentional
resources. The patient should respond by touching the non-
alcohol stimulus on the screen as fast and accurately as possible.
During the sessions, the speed at which the stimuli are presented
systematically increases, while the width of the outlines decreases
and gradually fades away in the final sessions. This increases the
difficulty of the task and trains the person’s attentional system so
that the alcohol-related stimuli are ignored even when there is
no color cue. In case the patient makes a mistake and touches the
incorrect stimulus, the tablet will provide an auditory-visual alert.
The training, therefore, occurs in seven hierarchical steps,
which are arranged according to an increasing level of difficulty.
Prior to each session, the patient will be encouraged to set a
goal for decreasing his or her reaction times (RTs) to the neutral,
non-alcohol-related stimuli, which requires increasing efficiency
for the distracting cues to be ignored. The goal will be for each
participant to improve his or her attentional control until a
performance plateau has been reached (RTs < 1,000ms with a
response accuracy > 90%).
After completing each session, the participant will be given
numerical/graphical feedback on (a) the number of errors
made and the mean RTs to the non-alcohol-related stimuli,
and (b) a brief auditory/written interpretation of the results.
The aim of the training will be to motivate patients to
actively take part in the program in a meaningful and goal-
directed way. Although the conventional AACTP includes some
gamification elements, the smartphone application includes
additional gamification elements, such as time-pressure, sound-
effects, hierarchical levels, feedback, achievement ranking, and
competition. These elements serve to increase the patient’s
engagement and compliance. Also, to increase engagement
and the chances of obtaining a dose-response effect across
participants, the application can control for the number of
practice sessions that each trainee can complete in each period,
and it can automatically save and securely encrypt and send the
training data to the research server via an internet connection.
Attentional Control Training Program Sham Training
via a Smartphone Application
The AACTP sham control training is like the AACTP in
that it is delivered via a smartphone application based on an
Android or iOS application and is designed in accordance with
the conventional program. Patients receiving the sham control
program will also have the application installed on their personal
smartphone. They, therefore, will be able to use the program
in any location that they wish. However, different from the
AACTP, patients in the active control group will be trained to
direct their attention toward the non-alcohol-related stimuli on
only 50% of the trials. On the remaining trials, their attention
will be directed toward the alcohol-related stimuli. Thus, the
sham training should counteract the induction of AB with AB
re-training because the allocation of the participant’s attention
will distribute equally between the alcohol-related and the non-
alcohol-related stimuli. The patient will respond by touching the
circle displayed on the computer screen as quickly and accurately
as possible. Like the ACTP training, a red outline will signal
a stimulus that should be ignored, and a green outline will
signal a neutral stimulus, which should be responded to, but
the alcoholic or non-alcoholic stimuli will appear equally often
with the red or green outline. Also, throughout each session,
the speed at which the stimuli are presented will systematically
increase, and the width of the outlines will decrease and gradually
fade away in the final sessions, thereby increasing the difficulty
of the task. In case the patient makes an error and touches an
incorrect stimulus, the tablet will provide an auditory-visual alert.
As in the smartphone version of the alcohol ACTP, prior to
each session the participant will be encouraged to set a goal for
the speed of the reaction times and the number of errors made
Frontiers in Psychiatry | www.frontiersin.org 5 November 2021 | Volume 12 | Article 748848
Mellentin et al. Attentional Control Training
until his or her performance plateau has been reached. After
completing each session, the patient will be given both graphical
and auditory feedback. Hence, the program will contain all the
same features as the smartphone version of the alcohol ACTP.
The only difference is that the patient’s attention will be equally
guided toward non-alcohol-related and alcohol-related stimuli in
the sham control version. Selected practice data will be sent to
the server to control for dose-response effects. Having the sham
condition is important for ensuring that effects obtained with
the smartphone version of the alcohol ACTP result from the re-
training of the patients’ alcohol attentional bias and not from
the additional attention that they receive or from some other
unintended effect, such as the Hawthorne effect (53).
Treatment as Usual
Patients in the Treatment-As-Usual (TAU) (see Section
2.2.) control group will not receive any kind of additional
treatment, because we aim to determine whether the smartphone
version of the alcohol ACTP will increase the effectiveness
of a well-established, evidence-based pharmacological and
psychological treatment.
Measures
Upon admission to the study, patients in all three or the groups
will be assessed in a baseline interview. Details about patients’
socio-demographic characteristics, AUD diagnosis, treatment
goals, and pharmacological treatment will be obtained from
their clinical records (54–56). At baseline, the general premorbid
intelligence level and cognitive functioning will be assessed.
Experimental measures of patients’ cue-induced cravings, alcohol
AB, action-tendency bias, inhibition bias, and cognitive flexibility
(24, 26, 27, 57, 58) will be administered at baseline and post-
treatment. Clinical measures of patients’ alcohol consumption
(the primary outcome measure), cravings, self-efficacy, and
affective states (the secondary outcomemeasures) (57–62) will be
taken at the baseline, post-treatment, and follow-up assessments.
The follow-ups will be given at 3- and 6-months post-treatment.
Baseline Measures of General Cognitive Functioning
National Adult Reading Task. The Danish version of the
National Adult Reading Task (DART/NART) (63) assesses
verbal crystalized intelligence, which is indicative of general
premorbid cognitive functioning. Respondents are asked to read
50 incongruent words in Danish (i.e., the pronunciation does not
correspond with how the word is spelled). The total DART score
can be converted to an intelligence quotient score (IQ score).
Montreal Cognitive Assessment. The Montreal Cognitive
Assessment (MOCA) is a short screening tool that is sensitive
to mild cognitive impairment. It assesses six cognitive domains:
attention, orientation, executive functioning, visuospatial
construction, memory, and language (64). The MOCA consists
of short cognitive tasks that can be administered in 10 min.
Experimental Measures
Cue-Induced Cravings
Cravings for alcohol will be assessed by exposing patients to
14 alcohol-related pictures from the AACTP and 14 alcohol-
related pictures that were not included in the AACTP. The
aim is to determine whether cue-induced cravings will decrease
in the experimental AACTP group and whether the decrease
is generalized to alcohol-related stimuli not included in the
AACTP. Cue-induced cravings in response to the pictures will
be measured using (a) self-report by means of a visual-analog
scale (see Section 2.6.2.2. for a description) (57, 58) and (b)
physiological reactivity by means of skin conductance response
using Imotions, which is a computerized system that has been
used in various experimental studies.
Cognitive Flexibility
The classic Stroop task will be used to measure patients’ degree of
general attentional control. Task stimuli consisting of two types
of words are used: (1) Congruent words comprise the names of
four colors (i.e., red, yellow, blue, and green) that are written in
a color that is congruent with the name of the color (e.g., the
word red in red letters); (2) Incongruent words consist of the
same four names of colors, but they are presented in a font color
that is incongruent with the name of the color (e.g., the word red
in blue letters). The patient’s task is to name the color in which
the words are presented while attempting to ignore the meaning
of the word. Both the mean reaction time for correctly naming
the color of the words and the number of correct responses
(mean accuracy) will be recorded. Subtracting mean reaction
time to the congruent words from the mean reaction time to the
incongruent words gives a measure of the participant’s cognitive
interference (26).
Alcohol Attentional Bias
Patients’ AB for alcohol cues will be assessed using the alcohol
Stroop task. The task consists of two categories of words
presented in different font colors (i.e., red, yellow, blue, and
green): (1) alcohol-related words (e.g., bar, beer, rum, scotch,
tequila, vodka, whisky), and (2) neutral words (e.g., ceiling,
cupboard, fence, gate, shed, tap, chair). The two categories of
words are matched for word frequency and length, number of
syllables, and semantic relatedness. As in the classic Stroop task,
the patient’s task will be to name the color in which the words are
presented while attempting to ignore the meaning of the words.
AB is indicated by longer reaction times to the alcohol-related
words relative to the neutral words (27, 32).
In this study, the alcohol Stroop task with pictures will
also be used to measure patients’ AB for alcohol cues, thereby
indicating whether patients have benefitted from the AACTP
training. To determine this, the task will consist of pictures
of alcoholic and non-alcoholic beverages, each presented with
colored outlines (i.e., red, yellow, blue, or green): (1) pictures
of alcoholic beverages (e.g., beer, wine, spirits), and (2) pictures
of non-alcoholic beverages (e.g., water, orange juice, smoothie).
Alcohol AB is indicated by longer reaction times to the alcohol
cues than to the non-alcoholic cues (24).
Attentional Bias Measured With Eye Tracker
Multi-stimulus free-viewing task (MSFVT). The MSFVT will be
used to also measure patients’ AB for alcohol cues. The task
consists of 54matrices, each containing pictures of eight alcoholic
and eight non-alcoholic drinks. Each matrix will be presented
for 6 s. The task consists of three blocks of 18 trials. Unlike the
Frontiers in Psychiatry | www.frontiersin.org 6 November 2021 | Volume 12 | Article 748848
Mellentin et al. Attentional Control Training
alcohol Stroop task, this task is not based on reaction times;
instead, it involves eye tracking. For each matrix, the patient is
required to gaze at a fixation dot in the center of the screen for
100ms for the matrix to appear. After a further 2,000ms interval,
the next fixation dot appears (65, 66). Tracking of the patient’s
eyes will, like the other physiological measure (skin conductance
response), be recorded using Imotions.
Alcohol Action Tendency and Inhibition Bias
Alcohol approach-avoidance task (AAT): The AAT measures the
degree of alcohol approach bias. During the AAT, patients are
requested to react to pictures of the alcoholic drinks by using
avoidance responses (i.e., by pushing a joystick away from
themselves) and to react to the pictures of non-alcoholic drinks
using approach responses (i.e., by pulling a joystick toward
themselves). The mean reaction time and the number of correct
approach and avoidance responses will be recorded. Similar to
AB, approach bias is indicated when reaction times are faster for
approaching alcohol cues than for avoiding them, whereas the
opposite indicates an avoidance bias (67, 68).
Alcohol Go/No-Go (A-GNG) task: Patients’ response
inhibition for alcohol cues will be recorded with the A-GNG
(69, 70). Here, the patient must respond to pictures of non-
alcoholic drinks (e.g.., a bottle of coke or of water; the Go
stimuli) and inhibit their responses to alcoholic stimuli (e.g., a
bottle of beer; the No-Go stimuli). The following indices will
be recorded: Number of commission errors (i.e., false alarms
or erroneously responding to no-go stimuli), omission errors
(i.e.., misses or failing to react on go-stimuli), accuracy (i.e.,
hits or the number of correct responses for go-stimuli), and the
reaction times for the trials with correct response on go-trials. A
high rate of commission errors would indicate that the patient
has reduced inhibitory control, whereas a large number of
omission errors would indicate lapses in attention (71). To avoid
potential practice effects from the baseline to the post-treatment
assessments of the experimental tasks, two parallel versions of
the experimental tasks will be used.
Clinical Outcomes
Primary Outcome Measures
Alcohol consumption will be measured with the Alcohol
Timeline Follow-back (TLFB) method. It involves using a
calendar to help the patient retrospectively recall the number of
drinks that he/she consumed on each day during the previous
3 months (59, 72). The results will be used to calculate various
alcohol consumptionmeasures, including weekly mean drinking,
which will be the primary outcome measure.
To validate the TLFB, hair samples from the patients will be
tested for ethyl glucuronide (ETG) by liquid chromatography-
tandem mass spectrometry (LC-MS/MS). This biological marker
of alcohol consumption will be collected and analyzed according
to the Society for Hair Testing (73, 74).
Secondary Outcome Measures
A visual analog scale (VAS) will be used to measure patients’
alcohol cravings on a scale ranging from 0 to 10, with 0 indicating
no craving at all and 10 indicating extreme craving. The scale
will be presented visually on a ruler, and patients will be asked
to indicate their mean and peak level of craving during the past
30 days (57, 58).
The Alcohol Abstinence Self-Efficacy Scale is a 40-item
measure of patients’ temptation to drink and their perceived self-
efficacy in abstaining from drinking in 20 different situations
that represent typical cues for drinking. Twenty items pertain
to temptation, and 20 items pertain to self-efficacy. Patients will
rate each item on a scale ranging from not at all (0) to extremely
(4). The measure comprises the following sub-scales: (1) negative
affect; (2) social interaction and positive states; (3) physical and
other concerns; and (4) withdrawal and urges to drink. Both the
temptation and perceived efficacy total score can range from 0 to
80 (60).
The Readiness-to-Change Questionnaire Treatment Version
(RTCQ-TV) is a 12-itemmeasure of patients’ stated intentions to
change their drinking, which includes the following sub-scales:
(1) pre-contemplation, (2) contemplation, and (3) action stages.
Four items pertain to each sub-scale, and each item is rated
on a 5-point Likert Scale ranging from strongly agree (−2) to
strongly disagree (+2). The total score can range from −24 to
+24 (61, 75).
The Positive and Negative Affect Schedule (PANAS) is a 20-
item measure of the patient’s affective states, which includes two
sub-scales: (1) positive affect and (2) negative affect. Ten items
pertain to each sub-scale, and each item is rated on a 5-point scale
ranging from 1 (not at all) to 5 (very much). The total score can
range from 20 to 100 (62).
Statistical Analysis
The intent-to-treat principle will be followed in the analyses
to evaluate the intervention. A repeated-measures MANOVA
with groups as the between-participants factor and assessment
time-point as the within-participants factor will be used to test
the efficacy of the intervention across the assessment points.
Efficacy would be indicated by a significant Time X Study Group
interaction. Each of the significant interactions will be followed
up with post-hoc tests to identify the source of the interaction.
Potential demographic covariates (e.g., age, education, income)
will also be considered by using MANCOVA. Further, attrition
rate at each follow-up time point will be evaluated. Baseline
characteristics of participants who remain in the study will be
compared with those who have been lost to follow-up. Amultiple
imputation (MI) approach that adjusts for uncertainty arising
from missing data (76, 77) will also be conducted to evaluate the
main findings.
Based on MacKinnon (78) mediational procedures, a series
of regression analyses will be conducted to test the hypothesized
mediational relationships among the outcome variables, i.e., that
reductions in alcohol AB and cravings will partially mediate
improvements in the outcome measures. Several ancillary
interaction effects will also be evaluated, although they are
not hypothesized to be significant. They include potential
interactions between the intervention received and patients’
drinking history, affective states, and cognitive flexibility.
Although the intervention is intended to be effective for all AUD
patients, it is important to test this assumption by evaluating
Frontiers in Psychiatry | www.frontiersin.org 7 November 2021 | Volume 12 | Article 748848
Mellentin et al. Attentional Control Training
whether the intervention is effective for specific sub-groups
of patients.
A power analysis (79, 80) was conducted using G∗Power
for a repeated-measures MANOVA with α = 0.05; effect size
(ES) of f =0.20; power = 0.90; groups k = 3; and time-points
measurements= 4. It showed that 88 participants will be required
for the final analyses in each of the four cells (total N = 264).
Prior evaluations identified f s of 0.30 (AB) and 0.37 (weekly
mean drinking) and an f of 0.42 (situational confidence to
resist drinking) on outcome measures for sub-clinical excessive
drinkers (36). Further, in a study that used the intervention as an
add-on treatment for clinical participants with a substance-use
disorders other than AUD, effect sizes of f s= 0.33 (drug-specific
AB), 0.34 (number of relapses), 0.32 (temptation to use) and 0.37
(self-confidence to resist temptation) were identified (42). Also,
an unpublished study conducted with detoxified drug-abusers
found f s of 0.39 (drug-specific AB), 0.18 (number of relapses),
and 0.35 (temptation to use) (81). A second power analysis for a
MANOVA with special effects and interactions was conducted to
test the dosage-effect across groups (α = 0.05; EF f 2(v) = 0.06;
power= 0.90; k= 3; predictors= 3; and response variables= 8),
which yielded anN of 220. Attrition in similar studies has usually
ranged from 10 to 15% (41, 42). Assuming a somewhat higher
attrition rate (20%), which is not unlikely (82, 83), indicates that
317 (264 + [264·0.20]) participants should be tested at baseline
for an analysis using listwise deletion of missing cases, although
a multiple imputation (MI) analysis will also be conducted to
verify that results converge across missing data assumptions. The
projected sample size is sufficient for the planned data analyses,
including mediational analyses based on Fitz and MacKinnon’s
guidelines (84).
Ethics
The patients in this study will undergo primary treatment
in the outpatient clinics. Although 66% of them will not
receive additional treatment, all patients will be treated with
the standard evidence-based AUD treatment. Thus, we find no
ethical problems with not offering the add-on intervention to
the entire sample. However, a critical ethical question is whether
use of the ACTP would encourage patients randomized to the
experimental group to consume alcohol instead of discouraging
them for doing so. This concern relates to the fact that ACTP
involves in vivo exposure to alcohol through the alcohol-related
pictures. However, in Western cultures, all patients will be
continuously exposed to alcohol cues, both during and after
treatment, and they will be unable to avoid this because large-
scale alcohol advertisements are continuously on public display
in magazines and on television. Also, in Denmark alcohol is
readily available, highly visible, and easy to buy around the
clock in supermarkets, delicatessens, kiosks, and service stations.
We, therefore, consider exposure to the alcohol pictures in the
experimental group to be no riskier for patients than exposure
to them in everyday life. By contrast, in the experimental group,
the patients will be trained to focus less on alcohol cues and more
on non-alcoholic drinks than in real life. Furthermore, the ACTP
will be available only during the opening hours of the alcohol
outpatient clinics, and patients in the experimental groups will
be provided with a direct telephone number of a therapist in case
they experience uncontrollable cravings. Patients in all three of
the groups will have the option to call a therapist. All attempts
will be taken to intervene in case a patient relapse. The protocol
has been approved by the Regional Scientific Ethical Committees
for Southern Denmark (Project ID: S-20200200).
DISCUSSION
The present study will investigate whether (1) the AACTP as
an add-on intervention increases the effectiveness of a primary
evidence-based treatment, and (2) a gamified version of AACTP
can be successfully delivered via a smartphone application as an
add-on. As mentioned in the introduction, the alcohol ACTP
has been evaluated in community samples of excessive drinkers,
for whom reductions in AB and alcohol consumption were
observed post-treatment and at follow-up (32, 36, 37). In the first
experimental study, it was found that individuals with harmful
alcohol use (drinking > 50 units per week for men and > 35
units per week for women) showed reductions in both AB and
alcohol consumption at post-treatment, and these reductions
were maintained at a 3-month follow-up (32). In this initial
study, the participants served as their own controls, which is
a commonly used method in an initial evaluation of a new
intervention (85). Hence, after recruitment and assessment, there
was, in accordance with this alternative tradition, a waiting
period before ACTP was started, and during this period there
was no change in either AB or alcohol consumption, but there
was a decline in both measures following the introduction
of the AACTP intervention 1 month later (32). Similarly, a
second randomized controlled study of a sub-clinical sample of
hazardous drinkers (22–50 units per week for men and 15–35
units per week for women) and persons with harmful alcohol
use found that the ACTP (compared to a non-active control
group) was effective in decreasing alcohol consumption at post-
treatment and at the 3-month follow-up, but the reductions had
attenuated at the 6-month follow-up (36). A third randomized
controlled study investigated whether the AATCP could be
successfully delivered via a fully automated web-based delivery
pathway to a community sample of hazardous drinkers. At post-
intervention, a reduction in both alcohol craving and alcohol
consumption was found in the AACTP group compared to
an active sham-control group. However, the effects on alcohol
consumption were not maintained at the 3-month follow-up
(37). Finally, a fourth study tested a gamified AACTP delivered
though a smartphone application in another community sample
of hazardous drinkers (18–40 years old). Results indicated that
reductions of up to 40% in alcohol consumption had occurred
several months after the training (86).
The fact that the AACTP has to date been tested only in
community samples of excessive drinkers highlights the need for
this program to be tested in clinical AUD samples to determine
its effectiveness as a clinical treatment. There are various facets
of the training that might need to be altered when using it in a
clinical setting. For instance, it might be necessary to increase
the number of the AACTP training sessions, because clinical
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samples have a stronger AB than community samples, and the
AACTPmight have specific dosage effects. Furthermore, whereas
prior studies conducted with community samples have treated
individuals only with the AACTP, this may not be sufficient for
treating AUD patients in a clinical setting. For instance, it might
be that the AACTP works best when it is used as an add-on to
an existing treatment. That is, changing the attentional pattern
of selective attention for alcohol cues may be essential but not
sufficient for bringing about enduring changes in the addictive
behavior. Combining the AACTP with another treatment, such
as CBT, might be more effective in the long term than would
treatment when delivered separately. Combining psychological
treatments that address AUD-related cognitive dysfunctions in
the reflective and impulsive systems might better prepare patients
for their inevitable confrontation with alcohol cues in their
natural environment and increase the probability of preventing
relapses in the longer term. In short, rigorous, and well-powered
clinical studies are needed before firm conclusions can be reached
about whether the AACTP is an effective clinical treatment.
In recent years, advances on the internet and mobile
technologies have made it possible for neuropsychological
treatments, such as the AACTP, to be used outside the laboratory,
and several pioneering studies have been conducted to test the
effects of this approach. For instance, as mentioned earlier,
Wiers et al. (37) administered the AACTP over the Internet in
its conventional form and found a reduction in users’ alcohol
consumption (37). Cox et al. (36) administered a gamified
AACTP smartphone application and also found both short-term
and longer-term reductions in alcohol consumption (86). The
AACTP in its original form has some gamification elements
(e.g., a progression in level of difficulty, goal-setting, feedback,
and time pressure), and Wiers et al.’s (37) study along with
other pioneering studies highlight the potential for cognitive-bias
modification to be delivered over the Internet.
Clinical neuropsychological treatments, including the
AACTP, have shown great promise in treating cognitive
dysfunctions not targeted by conventional psychological
treatments, and the use of gamification elements may also
enhance compliance and the effectiveness of these interventions,
as Cox et al. (36) initially confirmed with their gamified version
of the AACTP. However, as these authors also note, it is
important to be mindful of the target audience when delivering a
gamified neuropsychological treatment.
The use of the Internet and mobile devices to deliver a
novel treatment to adults might help us improve standard
evidence-based treatments for AUD and related disorders (2–
4). However, although eHealth-based interventions might have
major advantages in terms of increasing availability and reducing
the socio-economic burden on society, when targeting clinical
AUD populations, these interventions should be delivered only
as an add-on for increasing the effectiveness of a treatment
that has already been proven to be effective. Because AB for
alcohol cues is proportional to the amount of alcohol habitually
consumed, and these biases are not addressed within current
evidence-based treatment programs, this study is expected to
provide new evidence regarding the effectiveness of the gamified
AACTP in a clinical population. Furthermore, the intervention
should also provide valuable insights into implicit cognitive
processes and relationships among alcohol ABs, action-tendency
bias (i.e., approach-avoidance bias), and inhibition bias. These
implicit processes have all been studied extensively in patients
with AUD (16, 25, 87), but there is still a need formore integrative
evidence on the associations between the various types of alcohol-
related cognitive biases and their role in the maintenance of
addictive behaviors (88).
If this study demonstrates that AACTP is effective in
patients with AUD, other means of assessing ABs and
delivering cognitive training programs could be implemented
by utilizing technologies such as virtual reality (VR) and
augmented reality [AR; (89)]. These technologies have already
been developed for targeting approach biases through the
approach avoidance training program (90). Paradigms using
VR and AR might overcome some of the shortcomings
of the AACTP by increasing its ecological validity. The
multimodal nature of these paradigms might cause them
to be perceived as closer to real-life situations than other
eHealth options (91). Nonetheless, the implementation
of VR and AR technologies is an emerging field of
research, and the exact implications of their efficacy and
effectiveness in treatments targeting AB in AUDs are yet to be
examined (91).
Overall, the promising results from the use of AACTP in
community samples suggest that the AACTP treatment in this
study will be effective, thus paving the way for such a treatment
to be implemented in clinical settings. We expect that this study
will increase the effectiveness of an existing evidence-based AUD
treatment (i.e., CBT) and that it will show that a low-cost and
easily available gamified treatment is also effective. Thus, this
study is likely to have an impact at the scientific, clinical, and
societal level.
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